Hepatitis G and Erythropoietin Therapy in Patients Undergoing Hemodialysis

Diagnosing latent tuberculosis infection in haemodialysis patients: T-cell based assay (T-SPOT.TB) or tuberculin skin test?

“…Patients with end-stage renal disease (ESRD) who are on haemodialysis (HD) have a significantly higher incidence of Mycobacterium tuberculosis infection or disease than healthy individuals [1][2][3][4][5][6]. Most cases of active tuberculosis (TB) in patients with ESRD are due to the reactivation of a latent infection, and this patient group is at roughly 10-to 25-fold higher risk for reactivating TB infection than the general population [1][2][3]. Moreover, HD units have been shown to be important centres for the spread of infectious TB [7][8][9].…”

Low Prevalence of Serum HGV-RNA among Patients with Chronic Renal Failure without Dialysis

“…Hepatitis viruses have become one of the main infectious problems in patients on long-term hemodialysis [2][3][4][5]. Despite screening of blood products for hepatitis and the wide use of erythropoietin, which reduces blood transfusion requirements, some patients still become infected with hepatitis G during hemodialysis [6]. It has also been reported that HGV was common in a group of volunteer blood donors, and it can be transmitted by transfusion [7].…”